Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 118(21)2021 05 25.
Artigo em Inglês | MEDLINE | ID: mdl-34006635

RESUMO

Spatiotemporal regulation of signaling cascades is crucial for various biological pathways, under the control of a range of scaffolding proteins. The BNIP-2 and Cdc42GAP Homology (BCH) domain is a highly conserved module that targets small GTPases and their regulators. Proteins bearing BCH domains are key for driving cell elongation, retraction, membrane protrusion, and other aspects of active morphogenesis during cell migration, myoblast differentiation, and neuritogenesis. We previously showed that the BCH domain of p50RhoGAP (ARHGAP1) sequesters RhoA from inactivation by its adjacent GAP domain; however, the underlying molecular mechanism for RhoA inactivation by p50RhoGAP remains unknown. Here, we report the crystal structure of the BCH domain of p50RhoGAP Schizosaccharomyces pombe and model the human p50RhoGAP BCH domain to understand its regulatory function using in vitro and cell line studies. We show that the BCH domain adopts an intertwined dimeric structure with asymmetric monomers and harbors a unique RhoA-binding loop and a lipid-binding pocket that anchors prenylated RhoA. Interestingly, the ß5-strand of the BCH domain is involved in an intermolecular ß-sheet, which is crucial for inhibition of the adjacent GAP domain. A destabilizing mutation in the ß5-strand triggers the release of the GAP domain from autoinhibition. This renders p50RhoGAP active, thereby leading to RhoA inactivation and increased self-association of p50RhoGAP molecules via their BCH domains. Our results offer key insight into the concerted spatiotemporal regulation of Rho activity by BCH domain-containing proteins.


Assuntos
Diferenciação Celular/genética , Proteínas Ativadoras de GTPase/ultraestrutura , Morfogênese/genética , Proteína cdc42 de Ligação ao GTP/ultraestrutura , Proteína rhoA de Ligação ao GTP/ultraestrutura , Sequência de Aminoácidos/genética , Proteínas de Transporte/genética , Proteínas de Transporte/ultraestrutura , Linhagem Celular , Movimento Celular/genética , Endocitose/genética , Proteínas Ativadoras de GTPase/genética , Humanos , Ligação Proteica/genética , Estrutura Terciária de Proteína , Schizosaccharomyces/genética , Homologia de Sequência de Aminoácidos , Transdução de Sinais/genética , Proteína cdc42 de Ligação ao GTP/genética , Proteína rhoA de Ligação ao GTP/genética
2.
BMC Musculoskelet Disord ; 12: 146, 2011 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-21718535

RESUMO

BACKGROUND: To study the effects of zoledronic acid (ZA) on the vasculogenic mimicry of osteosarcoma cells in vitro. METHODS: A Three-dimensional culture of LM8 osteosarcoma cells on a type I collagen matrix was used to investigate whether osteosarcoma cells can develop vasculogenic mimicry, and to determine the effects of ZA on this process. In addition, the cellular ultrastructural changes were observed using scanning electron microscopy and laser confocal microscopy. The effects of ZA on the translocation of RhoA protein from the cytosol to the membrane in LM8 cells were measured via immunoblotting. RESULTS: ZA inhibited the development of vasculogenic mimicry by the LM8 osteosarcoma cells, decreased microvilli formation on the cell surface, and disrupted the F-actin cytoskeleton. ZA prevented translocation of RhoA protein from the cytosol to the membrane in LM8 cells. CONCLUSIONS: ZA can impair RhoA membrane localization in LM8 cells, causing obvious changes in the ultrastructure of osteosarcoma cells and induce cell apoptosis, which may be one of the underlying mechanisms by which the agent inhibits the development of vasculogenic mimicry by the LM8 cells.


Assuntos
Inibidores da Angiogênese/farmacologia , Neoplasias Ósseas/irrigação sanguínea , Neoplasias Ósseas/tratamento farmacológico , Difosfonatos/farmacologia , Imidazóis/farmacologia , Neovascularização Patológica/patologia , Neovascularização Patológica/prevenção & controle , Osteossarcoma/irrigação sanguínea , Osteossarcoma/tratamento farmacológico , Animais , Conservadores da Densidade Óssea/farmacologia , Neoplasias Ósseas/ultraestrutura , Linhagem Celular Tumoral , Camundongos , Microvilosidades/efeitos dos fármacos , Microvilosidades/patologia , Microvilosidades/ultraestrutura , Neovascularização Patológica/tratamento farmacológico , Técnicas de Cultura de Órgãos , Osteossarcoma/ultraestrutura , Transporte Proteico/efeitos dos fármacos , Transporte Proteico/fisiologia , Ácido Zoledrônico , Proteína rhoA de Ligação ao GTP/metabolismo , Proteína rhoA de Ligação ao GTP/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA